DL-AP7 nkoside M and Preclinical Characterization of Selective

and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway

and it is a secretory enzyme important for converting lysophosphatidylchloine (LPC) into lysophosphatidic acid (LPA) as a bioactive signaling molecule

AZ 10417808 completely blocked the staurosporine-induced intracellular DEVDase activity and this effect was dose-dependent

but increases Nrf2 protein level due to targeting the Nrf2 binding site on Keap1

Smiles: [2H]C1(C(CC#N)N2C=C(C=N2)C2N=CN=C3NC=CC=23)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H]

DL-AP7 nkoside M and Preclinical Characterization of SelectiveProduct information CAS Number: 78966 69 5 Molecular Weight: 225. 18 Formula: C7H16NO5P Chemical Name: 2 amino 7 phosphonoheptanoic acid Smiles: NC(CCCCCP(O)(O)=O)C(O)=O InChiKey: MYDMWESTDPJANS UHFFFAOYSA N InChi: InChI=1S C7H16NO5P c8 6(7(9)10)4 2 1 3 5 14(11,12)13 h6H,1 5,8H2,(H,9,10)(H2,11,12,13) Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Shipping Condition: Shipped under ambient temperature as non